Research News

BrightFocus Foundation today lauded a new, innovative citizen science project, EyesOnALZ, which recently launched an online game - Stall Catchers - to engage the public in helping researchers analyze Alzheimer’s data in the hopes of more quickly discovering ways to prevent and treat the disease.

Real World Health Care talks with Diane Bovenkamp, Ph.D., Scientific Program Officer for BrightFocus Foundation, about the basic science and therapeutic research the Foundation is funding.

Time magazine recently described a “cocktail” approach to fighting Alzheimer’s. BrightFocus-funded research supports this effort, which takes us closer to a cure.

Stacy Pagos Haller, BrightFocus Foundation's President and CEO, urges the Food and Drug Administration to strongly support expanded use of neurodiagnostic tools to assess cognitive function.

Research by BrightFocus grantee Matthew Campbell, PhD, of Trinity College Dublin, represents a potential new way to help clear the brain of a build-up of the toxic amyloid beta (Aβ) that leads to Alzheimer’s.

Researchers funded by BrightFocus Foundation are bringing us closer to preventing the spread of Alzheimer’s disease in the brain. Learn more about this exciting research.

BrightFocus-funded Dr. Maya Koronyo-Hamaoui is the senior author on a groundbreaking publication that reported the ACE protein, which can increase blood pressure to dangerous levels in the body’s blood stream, can actually help to clear beta-amyloid in the brain by stimulating the immune system.

Experts have long recognized that the number of deaths from Alzheimer’s disease (AD) tends to be underreported. Now a new study published in Neurology attempts to quantify that under-reporting and projects the AD mortality rate to be five to six times higher than official estimates, suggesting that AD may be responsible for more than 500,000 annual deaths in the United States.